Results 181 to 190 of about 756,852 (217)
Some of the next articles are maybe not open access.
2018
In this chapter the essential aspects of myasthenia gravis and Eaton-Lambert syndrome are reviewed. The chapter is divided into preoperative, intraoperative, and postoperative sections with important subtopics related to the main topic in each section.
openaire +1 more source
In this chapter the essential aspects of myasthenia gravis and Eaton-Lambert syndrome are reviewed. The chapter is divided into preoperative, intraoperative, and postoperative sections with important subtopics related to the main topic in each section.
openaire +1 more source
Seronegative generalized myasthenia gravis
Neurology, 1992We have reviewed thymus histology, preoperative serum acetylcholine receptor antibody status, and clinical features of all 50 patients who underwent thymectomy for generalized myasthenia gravis in the University of British Columbia-affiliated hospitals over the last 8 years.
P K, Verma, J J, Oger
openaire +2 more sources
Journal of Neuroimmune Pharmacology
Generalized myasthenia gravis (gMG) is an antibody mediated autoimmune neuromuscular junction disorder characterized by muscle weakness and fatigue as well as acetylcholine receptor antibody (AChR-Ab) as the main presence. A proportion of patients fail to achieve minimal symptom expression (MSE), furthermore 10-20% of them develop into refractory under
Ying, Zhu +3 more
openaire +2 more sources
Generalized myasthenia gravis (gMG) is an antibody mediated autoimmune neuromuscular junction disorder characterized by muscle weakness and fatigue as well as acetylcholine receptor antibody (AChR-Ab) as the main presence. A proportion of patients fail to achieve minimal symptom expression (MSE), furthermore 10-20% of them develop into refractory under
Ying, Zhu +3 more
openaire +2 more sources
Frequency of seronegativity in adult‐acquired generalized myasthenia gravis
Muscle & Nerve, 2007AbstractWe determined the prevalence of muscle acetylcholine receptor (AChR) antibodies in patients with adult‐acquired generalized myasthenia gravis (MG), the seroconversion rate at 12 months, and the prevalence of muscle‐specific tyrosine kinase (MuSK) antibody among persistently seronegative patients.
Lennon, VA +3 more
openaire +4 more sources
Comment: Methotrexate for patients with generalized myasthenia gravis
Neurology, 2016Methotrexate (MTX) has long been a favorite drug of rheumatologists for treating rheumatoid arthritis, inflammatory myositis, and other autoimmune diseases. Why not myasthenia gravis (MG) as well? Reports of positive results of MTX treatment of MG led to this gold standard double-blind randomized controlled trial of MTX in patients with MG. The article
openaire +2 more sources
Correlation of C3 level with severity of generalized myasthenia gravis
Muscle & Nerve, 2009AbstractAcute exacerbation of generalized myasthenia gravis (GMG) can cause swallowing impairment, respiratory failure, or death. It is important to identify immunological factors that might be regarded reliably as an index of the patient's clinical condition, response to treatment, and measure of certain immune aberrations of MG.
Aidong, Liu +5 more
openaire +2 more sources
Successful treatment of refractory generalized myasthenia gravis with rituximab
European Journal of Neurology, 2009Objective: Myasthenia gravis (MG) is an autoimmune neuromuscular disorder for which current therapies carry a high risk of side‐effects and may be insufficient in stabilizing the clinical status. Many therapeutic options can be ruled, such as thymectomy, corticosteroids, azathioprine, cyclophosphamide, mycophenolate mofetil, methotrexate, intravenous ...
C, Lebrun +3 more
openaire +2 more sources
Development of Generalized Myasthenia Gravis in Patients With Ocular Myasthenia Gravis
Archives of Neurology, 2003T. H. Papapetropoulos +2 more
openaire +1 more source
Development of Generalized Myasthenia Gravis in Patients With Ocular Myasthenia Gravis—Reply
Archives of Neurology, 2003Peter Homel, Mark J. Kupersmith
openaire +1 more source